Pulmonary alveolar hemorrhage in systemic lupus erythematosus

https://doi.org/10.1016/S0049-0172(05)80022-8Get rights and content

Pulmonary alveolar hemorrhage (PAH) is a rare and often fatal presenting feature of systemic lupus erythematosus (SLE). Reported mortality rates are extremely high, 70% to 90%. Death frequently occurs within the first several days of the hemorrhage. The hospital records of all inpatients with PAH and SLE between April 1986 and May 1991 at the Hospital of the University of Pennsylvania were reviewed. The complete resolution of PAH and the 75% survival rate found in this study is in marked contrast to previous reports. This experience suggests that patients with PAH and SLE may have a better prognosis than previously reported.

References (27)

  • MintzG et al.

    Acute massive pulmonary hemorrhage in systemic lupus erythematosus

    J Rheumatol

    (1978)
  • BradleyDJ

    The pulmonary hemorrhage syndromes

    Clin Chest Med

    (1982)
  • EagenJW et al.

    The composition of pulmonary immune deposits in systemic lupus erythematosus

    Clin Immunol Immunopathol

    (1978)

    • Cited by (0)

    1

    From the Rheumatology Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

    2

    Edna P. Schwab, MD: Assistant Professor of Medicine, Medical College of Pennsylvania, Philadelphia VAMC Arthritis-Immunology Unit

    3

    H. Ralph Schumacher, Jr, MD: Professor of Medicine and Acting Chief, Rheumatology Division

    4

    Bruce Freundlich, MD: Associate Professor of Medicine, Rheumatology Division

    5

    Peter E. Callegari, MD: Assistant Professor of Medicine, Rheumatology Division.

    View full text
    Copyright © 1993 Published by Elsevier Inc.